WO2004032890A2 - Method for obtaining an active principle stimulating suntan and resulting active principle - Google Patents

Method for obtaining an active principle stimulating suntan and resulting active principle Download PDF

Info

Publication number
WO2004032890A2
WO2004032890A2 PCT/FR2003/002942 FR0302942W WO2004032890A2 WO 2004032890 A2 WO2004032890 A2 WO 2004032890A2 FR 0302942 W FR0302942 W FR 0302942W WO 2004032890 A2 WO2004032890 A2 WO 2004032890A2
Authority
WO
WIPO (PCT)
Prior art keywords
active principle
melanin
level
obtaining
skin
Prior art date
Application number
PCT/FR2003/002942
Other languages
French (fr)
Other versions
WO2004032890A3 (en
Inventor
Jean-Jacques Paufique
Original Assignee
Societe Industrielle Limousine D'application Biologique (Silab)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe Industrielle Limousine D'application Biologique (Silab) filed Critical Societe Industrielle Limousine D'application Biologique (Silab)
Priority to AU2003299762A priority Critical patent/AU2003299762A1/en
Publication of WO2004032890A2 publication Critical patent/WO2004032890A2/en
Publication of WO2004032890A3 publication Critical patent/WO2004032890A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/04Preparations for care of the skin for chemically tanning the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]

Definitions

  • the present invention relates to a process for obtaining an active principle for stimulating tanning as well as the active principle obtained.
  • tanning is an outward sign of good health, even if we know that these two parameters are in no way linked.
  • the body needs a slight daily exposure for the synthesis of vitamin D in particular but a very low exposure is largely sufficient.
  • tanning is rather a social sign which corresponds to a certain capacity to take vacations, in the sun and is the subject of one of the bases of social interviews.
  • melanin a pigment that gives the skin a more or less pronounced coloring.
  • melanin There are two types of melanin, eumelanin, brown in color and phaeomelanin, yellow-orange in color.
  • This pigment is synthesized by specific cells, melanocytes during a reaction, melanogenesis.
  • melanocytes during a reaction, melanogenesis.
  • This reaction is a defense reaction of the skin against the aggressions of the sun and more particularly of the ultraviolet rays of the sun.
  • UVB UVB
  • UVA As for UVA, they pass through the stratum corneum and 20 to 30% reach the deep dermis. These UVA are less energetic but are nonetheless dangerous and this permanently, throughout the exposure.
  • the skin's defense reactions result in a high production of melanin but also a thickening of the stratum corneum, a release of antioxidants or even by the use of repair systems for the DNA. It is necessary to include in suitable cosmetic compositions active agents having an action against induced damage such as free radicals. In addition, if we can speed up the process of elanogenesis by these same active ingredients, we can reduce the exposure time for the same degree of tan. Apart from the tanning of the skin obtained by stimulating melanogenesis under the effect of ultraviolet radiation, there are other means.
  • self-tanners which are creams or emulsions containing molecules such as DHA (dihydroxyacetone) or erytrulose (derivative of DHA), molecules which react with the amino acids of epidermal cells by developing a coloring of color and of variable intensity which resists water.
  • DHA dihydroxyacetone
  • erytrulose derivative of DHA
  • the different essential steps include a hydroxylation of tyrosine to dihydroxyphenylalanine (DOPA) by tyrosinase.
  • DOPA dihydroxyphenylalanine
  • This same enzyme also catalyzes the oxidation of DOPA to DOPAquinone.
  • the object of the present invention is to provide a process for obtaining an active principle which stimulates this activity of tyrosinase and therefore increases the synthesis of melanin.
  • Melanin absorbs more than 90% of the ultraviolet radiation that has passed through the stratum corneum.
  • Melanin polymers are capable of absorbing UV photons and cellular lipids. Melanin constitutes free radical traps thus protecting the melanocytes.
  • FIG. 1A a view of a histological section of an untreated, non-irradiated control explant
  • - Figure 1B a view of a histological section of a positive control explant treated and irradiated with UVB
  • FIG. 2A a view of a histological section of an explant treated with placebo and not irradiated
  • - Figure 2B a view of a histological section of an explant treated with placebo and irradiated with UVB
  • FIG. 3A a view of a histological section of an explant treated with the active principle of the present invention and not irradiated
  • FIG. 3B a view of a histological section of an explant treated with the active ingredient of the present invention and irradiated.
  • the process for obtaining the active principle of the present invention comprises the following steps: - solubilization of micronized powder of Citrus Aurantium Dulcis (sweet orange, immature fruit) in an aqueous solution at a rate of at least 50 g / l.
  • the measurement consists of starting from a liquid volume and measuring the residual dry matter after drying.
  • the pH is measured by the potentio etric method, at room temperature.
  • the pH is between 3.0 and 7.0, more particularly between 4.5 and 5.5.
  • the intensity of the coloring is proportional to the quantity of phenolic compounds, it suffices to compare with a standard range of hesperidin in the range, in this case 40 to 120 mg / l.
  • the content of phenolic compounds varies from 1.5 to 70 g / l, more particularly from
  • a C18 type column is used for this purpose, in particular that marketed under the name Alltech ltima C18., With a pre-column having the same characteristics.
  • a solution of formic acid and acetonitrile is used as solvents.
  • a detector at 280 nm allows the analysis and provides the following results:
  • the total sugar content is obtained by the DUBOIS method (DUBOIS M
  • DO is read in a spectrophotometer at 490 nm.
  • a test curve is established with a standard range of a combination of 1/3 of mannose, 1/3 of glucose and 1/3 of galactose, with concentrations of 25 to 100 ⁇ g / l.
  • the values of the sugar level are read directly from the curve and in the case of the active principle according to the present invention, values of total sugars are obtained between 1.5 and 70 g / l, more particularly 15 and 30 g / l .
  • the principle consists in studying the pigmenting activity of the active principle according to the present invention on melanocyte cultures by measuring the tyrosinase activity and the level of synthesized melanin.
  • the operating protocol consists in inoculating B16F1 melanocytes in a complete medium in the presence of 0.5%, 1% and 2% (volume / volume) of the active principle and the mixture is left to incubate under suitable conditions.
  • a positive control is carried out in parallel in the presence of -MSH (Melanocyte Stimuling Hormone), a hormone which stimulates melanogenesis.
  • the cells are trypsinized, counted and lysed.
  • This melanin level is determined relative to a standard range of synthetic melanin ranging from 0 to 500 ⁇ g / l.
  • the levels of melanin synthesized by melanocytes are summarized in the following table:
  • explants are treated topically with 2 mg / cm 2 of active principle according to the invention dosed at 5% for some, others are treated with a placebo medium and others, also called controls, remain only in the conservation medium.
  • the explants are irradiated every day.
  • the pigmentation of the explants treated with the active principle according to the invention is important. This pigmentation is all the more visible as the explants are subjected to UVB.
  • the study relates to human volunteers, the aim being to quantify the accelerating effect of tanning of an emulsion containing 5% of active principle according to the present invention, during and after the exposure to UV.
  • the tests are carried out against placebo on two areas of the forearms, the color of which is measured with a Chromameter, a device of the trade of the Minolta brand.
  • the emulsion containing the active principle and the placebo emulsion are applied twice a day for 15 days then these areas are irradiated twice at two days apart then 2 days after each irradiation, the color of the areas retained is again measured. and processed.
  • b is the parameter studied because it represents the yellow melanin skin pigmentation, characteristic of tanning.
  • One of the cosmetic formulas used and therefore capable of being produced industrially comprises:
  • the active principle can be introduced into any suitable cosmetic support such as an emulsion, a cream, a lotion, an ointment or a dispersion.
  • a method of tanning the skin consists in applying a composition containing 0.1% and 10.0% of active principle to cause a large increase in melanin.

Abstract

The invention concerns a method for obtaining an active principle stimulating tyrosinase activity to increase melanin synthesis, characterized in that it comprises the following successive steps: solubilizing micronized powder of Citrus Aurantium bulcis in an aqueous solution at a rate of at least 50 g/l, simultaneous or successive enzymatic hydrolyses with at least two enzymes selected among the carbohydrase and protease families, separating by filtration, centrifuging or decantantion, and selecting by filtration flavonone-type polyphenols.

Description

PROCEDE D'OBTENTION D'UN PRINCIPE /ACTIF DE STIMULATION DU BRONZAGE ET PRINCIPE ACTIF OBTENU PROCESS FOR OBTAINING A TANNING STIMULATION PRINCIPLE / ACTIVE, AND ACTIVE INGREDIENT OBTAINED
La présente invention concerne un procédé d'obtention d'un principe actif de stimulation du bronzage ainsi que le principe actif obtenu.The present invention relates to a process for obtaining an active principle for stimulating tanning as well as the active principle obtained.
Dans le monde occidental, particulièrement, il est un facteur de beauté particulièrement recherché, le bronzage ou pour le moins un teint hâlé. En effet, le bronzage est un signe extérieur de bonne santé, même si l'on sait que ces deux paramètres ne sont aucunement liés. Le corps a besoin d'une légère exposition journalière pour la synthèse de la vitamine D notamment mais une très faible exposition est largement suffisante.In the Western world, in particular, it is a particularly sought after factor of beauty, tanning or at least a tanned complexion. Indeed, tanning is an outward sign of good health, even if we know that these two parameters are in no way linked. The body needs a slight daily exposure for the synthesis of vitamin D in particular but a very low exposure is largely sufficient.
Plus spécifiquement, le bronzage est plutôt un signe social qui correspond à une certaine capacité à prendre des vacances, au soleil et fait l'objet d'une des bases des entretiens sociaux.More specifically, tanning is rather a social sign which corresponds to a certain capacity to take vacations, in the sun and is the subject of one of the bases of social interviews.
De ce fait, il existe une très forte demande de la part des consommateurs pour des méthodes ou des produits qui confèrent à la peau une coloration plus ou moins prononcée. La peau, les cheveux et les poils sont colorés par un pigment, la mélanine. Il existe deux types de mélanine, l'eumélanine de couleur brune et la phaeomélanine de couleur jaune-orangée.As a result, there is a very high demand from consumers for methods or products that give the skin a more or less pronounced coloring. The skin, hair and body hairs are colored by a pigment, melanin. There are two types of melanin, eumelanin, brown in color and phaeomelanin, yellow-orange in color.
Ce pigment est synthétisé par des cellules spécifiques les mélanocytes au cours d'une réaction, la mélanogenèse. Plus cette réaction est mise en oeuvre, plus la mélanine est synthétisée et plus la peau devient colorée. En fait, cette réaction est une réaction de défense de la peau contre les agressions du soleil et plus particulièrement des rayonnements ultraviolets du soleil.This pigment is synthesized by specific cells, melanocytes during a reaction, melanogenesis. The more this reaction is implemented, the more the melanin is synthesized and the more the skin becomes colored. In fact, this reaction is a defense reaction of the skin against the aggressions of the sun and more particularly of the ultraviolet rays of the sun.
On sait que ces UV ont des effets néfastes sur la santé car ces radiations sont plus ou moins pénétrantes. La majorité des UVB, de l'ordre de 70%, est arrêtée par la couche cornée mais 20% pénètrent jusqu'au corps muqueux et 10% atteignent le derme superficiel.We know that these UV rays have harmful effects on health because these radiations are more or less penetrating. The majority of UVB, around 70%, is stopped by the stratum corneum, but 20% penetrate to the mucous body and 10% reach the superficial dermis.
Quant aux UVA, ils traversent la couche cornée et 20 à 30% atteignent le derme profond. Ces UVA sont moins énergétiques mais n'en restent pas moins dangereux et ceci en permanence, tout au long de l'exposition.As for UVA, they pass through the stratum corneum and 20 to 30% reach the deep dermis. These UVA are less energetic but are nonetheless dangerous and this permanently, throughout the exposure.
Face à ces agressions, les réactions de défense de la peau se traduisent par une forte production de mélanine mais aussi un épaississement de la couche cornée, une libération d 'anti-oxydants ou encore par une mise en œuvre de systèmes de réparation de l'ADN. II faut inclure dans des compositions cosmétiques adaptées des actifs ayant une action contre les dommages induits tels que les radicaux libres. De plus, si l'on peut accélérer le processus de la élanogenèse par ces mêmes actifs, on peut réduire la durée d'exposition pour un même degré de hâle. Hormis le bronzage de la peau obtenu par une stimulation de la mélanogenèse sous l'effet des rayonnements ultraviolets, il existe d'autres moyens.Faced with these aggressions, the skin's defense reactions result in a high production of melanin but also a thickening of the stratum corneum, a release of antioxidants or even by the use of repair systems for the DNA. It is necessary to include in suitable cosmetic compositions active agents having an action against induced damage such as free radicals. In addition, if we can speed up the process of elanogenesis by these same active ingredients, we can reduce the exposure time for the same degree of tan. Apart from the tanning of the skin obtained by stimulating melanogenesis under the effect of ultraviolet radiation, there are other means.
On connaît ainsi les autobronzants qui sont des crèmes ou des émulsions contenant des molécules comme la DHA (dihydroxyacétone) ou l'érytrulose (dérivé de la DHA), molécules qui réagissent avec les acides aminés des cellules épider iques en développant une coloration de teinte et d'intensité variable qui résiste à l'eau.Thus self-tanners are known which are creams or emulsions containing molecules such as DHA (dihydroxyacetone) or erytrulose (derivative of DHA), molecules which react with the amino acids of epidermal cells by developing a coloring of color and of variable intensity which resists water.
Néanmoins, ces autobronzants ne présentent pas une durabilité suffisante pour certains consommateurs et la coloration brune ne subsiste que grâce à des applications régulières de ladite crème ou émulsion. Il existent enfin des actifs cosmétiques pig entogènes qui favorisent la production de mélanine et donc contribuent à accélérer le bronzage.However, these self-tanners do not have sufficient durability for certain consumers and the brown coloring only remains thanks to regular applications of said cream or emulsion. Finally, there are cosmetic active pigments which promote the production of melanin and therefore help to speed up tanning.
Le procédé et le principe actif selon la présente invention se positionnent dans cette catégorie. Dans ce type d'action, on sait que la synthèse de la mélanine, sous ses différentes formes, résulte d'une succession de réactions enzymatiques qui transforment un amino-acide, la tyrosine, en pigments mélaniques.The method and the active principle according to the present invention fall into this category. In this type of action, we know that the synthesis of melanin, in its different forms, results from a succession of enzymatic reactions which transform an amino acid, tyrosine, into melanin pigments.
Les différentes étapes essentielles comprennent une hydroxylation de la tyrosine en dihydroxyphénylalanine (DOPA) par la tyrosinase. Cette même enzyme catalyse aussi l'oxydation de la DOPA en DOPAquinone.The different essential steps include a hydroxylation of tyrosine to dihydroxyphenylalanine (DOPA) by tyrosinase. This same enzyme also catalyzes the oxidation of DOPA to DOPAquinone.
Par des réactions successives, cette DOPAquinone en présence de peptides tels que le glutathion et d'un amino-acide spécifique la cystéine, conduit à la synthèse de phaeomélanine et de d'eumélanine.Through successive reactions, this DOPAquinone in the presence of peptides such as glutathione and a specific amino acid cysteine, leads to the synthesis of phaeomelanin and of eumelanin.
Le but de la présente invention est de proposer un procédé d'obtention d'un principe actif qui stimule cette activité de la tyrosinase et augmente donc la synthèse de la mélanine.The object of the present invention is to provide a process for obtaining an active principle which stimulates this activity of tyrosinase and therefore increases the synthesis of melanin.
De ce fait, en stimulant cette synthèse, la pigmentation se renforce et joue son rδle protecteur au niveau de la peau en assurant une meilleure photoprotection.Therefore, by stimulating this synthesis, pigmentation is strengthened and plays its protective role in the skin, ensuring better photoprotection.
La mélanine permet d'absorber plus de 90% des rayonnements ultraviolets ayant franchi la couche cornée. Les polymères de mélanine sont capables d'absorber les photons UV et les lipides cellulaires. La mélanine constitue des pièges à radicaux libres protégeant ainsi les mélanocytes.Melanin absorbs more than 90% of the ultraviolet radiation that has passed through the stratum corneum. Melanin polymers are capable of absorbing UV photons and cellular lipids. Melanin constitutes free radical traps thus protecting the melanocytes.
Le procédé d'obtention et les caractéristiques du principe actif obtenu sont maintenant décrits en détail ainsi que les effets obtenus mesurés. Les figures annexées représentent :The process for obtaining and the characteristics of the active ingredient obtained are now described in detail as well as the effects obtained measured. The attached figures represent:
- figure 1A, une vue d'une coupe histologique d'un explant témoin non traité, non irradié, - figure 1B, une vue d'une coupe histologique d'un expiant témoin positif traité et irradié avec des UVB,- Figure 1A, a view of a histological section of an untreated, non-irradiated control explant, - Figure 1B, a view of a histological section of a positive control explant treated and irradiated with UVB,
- figure 2 A, une vue d'une coupe histologique d'un explant traité par le placebo et non irradié, - figure 2B, une vue d'une coupe histologique d'un explant traité par le placebo et irradié avec des UVB,- Figure 2A, a view of a histological section of an explant treated with placebo and not irradiated, - Figure 2B, a view of a histological section of an explant treated with placebo and irradiated with UVB,
- figure 3 A, une vue d'une coupe histologique d'un explant traité avec le principe actif de la présente invention et non irradié, etFIG. 3A, a view of a histological section of an explant treated with the active principle of the present invention and not irradiated, and
- figure 3B, une vue d'une coupe histologique d'un explant traité avec le principe actif de la présente invention et irradié.- Figure 3B, a view of a histological section of an explant treated with the active ingredient of the present invention and irradiated.
1/ PRINCIPE ACTIF 1-1 Procédé d'obtention :1 / ACTIVE INGREDIENT 1-1 Method of obtaining:
Le procédé d'obtention du principe actif de la présente invention comprend les étapes suivantes : - solubilisation de poudre micronisée de Citrus Aurantium Dulcis (orangette douce, fruit immature) dans une solution aqueuse à raison d'au moins 50 g/l.The process for obtaining the active principle of the present invention comprises the following steps: - solubilization of micronized powder of Citrus Aurantium Dulcis (sweet orange, immature fruit) in an aqueous solution at a rate of at least 50 g / l.
- hydrolyses enzymatiques simultanées ou successives avec au moins deux enzymes choisies parmi les familles carbohydrases et protéases,- simultaneous or successive enzymatic hydrolysis with at least two enzymes chosen from the carbohydrase and protease families,
- séparation des phases soluble et insoluble par filtration, centrifugation ou décantation, et- separation of the soluble and insoluble phases by filtration, centrifugation or decantation, and
- sélection par filtration des polyphénols de type f lavonones.- selection by filtration of polyphenols of type f lavonones.
1-2 Taux de matière sèche '•1-2 Dry matter rate •
La mesure consiste à partir d'un volume liquide et à mesurer la matière sèche résiduelle après dessiccation.The measurement consists of starting from a liquid volume and measuring the residual dry matter after drying.
Aussi, on verse 4g de liquide sur 4g de sable dans une cupule en aluminium. On place la cupule à l'étuve à 105°C jusqu'à obtention d'un poids constant. Le taux de matières sèches obtenu est compris entre 5 et 200 g/1, plus particulièrement entre 50 et 85 g/1.Also, pour 4g of liquid on 4g of sand in an aluminum cup. The cup is placed in an oven at 105 ° C until a constant weight is obtained. The dry matter content obtained is between 5 and 200 g / 1, more particularly between 50 and 85 g / 1.
1-3 Mesure du pH '.1-3 pH measurement.
Le pH est mesuré par la méthode potentio étrique, à température ambiante. Le pH est compris entre 3,0 et 7,0 plus particulièrement entre 4,5 et 5,5.The pH is measured by the potentio etric method, at room temperature. The pH is between 3.0 and 7.0, more particularly between 4.5 and 5.5.
1-4 Dosage des composés phénoliques :1-4 Determination of phenolic compounds:
On sait que les composés phénoliques forment en présence de ferricyanure de potassium des complexes colorés détectables.It is known that phenolic compounds form detectable colored complexes in the presence of potassium ferricyanide.
Comme l'intensité de la coloration est proportionnelle à la quantité de composés phénoliques, il suffit de comparer avec une gamme étalon d'hespéridine dans la plage, dans ce cas 40 à 120 mg/l.As the intensity of the coloring is proportional to the quantity of phenolic compounds, it suffices to compare with a standard range of hesperidin in the range, in this case 40 to 120 mg / l.
La teneur en composés phénoliques varie de 1,5 à 70 g/1, plus particulièrement deThe content of phenolic compounds varies from 1.5 to 70 g / l, more particularly from
15 à 30 g/1.15 to 30 g / 1.
1-5 Caractérisation des composés phénoliques totaux : La caractérisation des composés phénoliques est réalisée par CLHP,1-5 Characterization of total phenolic compounds: The characterization of phenolic compounds is carried out by HPLC,
Chromatographie Liquide Haute Performance.High Performance Liquid Chromatography.
On utilise à cet effet une colonne de type C18, notamment celle commercialisée sous la dénomination Alltech ltima C18., avec pré-colonne ayant les mêmes caractéristiques. On utilise comme solvants une solution d'acide formique et de l'acétonitrile.A C18 type column is used for this purpose, in particular that marketed under the name Alltech ltima C18., With a pre-column having the same characteristics. A solution of formic acid and acetonitrile is used as solvents.
Un gradient entre ces deux solvants permet de séparer les différents composés phénoliques.A gradient between these two solvents makes it possible to separate the different phenolic compounds.
Un détecteur à 280 nm permet l'analyse et de fournir les résultats suivants :A detector at 280 nm allows the analysis and provides the following results:
- flavonones (du type hespéridine) représentant au moins 35% et jusqu'à au moins 50% des polyphénols totaux.- flavonones (of the hesperidin type) representing at least 35% and up to at least 50% of the total polyphenols.
- f lavones (type lutéoline-7-glucoside)- f lavones (luteolin-7-glucoside type)
- acides hydroxycinnamiques (type acide chlorogénique et acide férulique). 1-6 Teneur en sucres totaux '•- hydroxycinnamic acids (chlorogenic acid and ferulic acid type). 1-6 Total sugar content '•
La teneur en sucres totaux est obtenue par la méthode de DUBOIS (DUBOIS MThe total sugar content is obtained by the DUBOIS method (DUBOIS M
& al, (1956) Analytical Chemistry, 28, N°3, p 350-356)& al, (1956) Analytical Chemistry, 28, N ° 3, p 350-356)
En présence de phénol et d'acide sulfurique concentré, les sucres réducteurs donnent un composé jaune-orangé. Après refroidissement, la Densité OptiqueIn the presence of phenol and concentrated sulfuric acid, the reducing sugars give a yellow-orange compound. After cooling, the Optical Density
DO est lue au spectrophotomètre à 490 nm. Une courbe test est établie avec une gamme étalon d'une combinaison de 1/3 de mannose, 1/3 de glucose et 1/3 de galactose, avec des concentrations de 25 à 100 μg/l.DO is read in a spectrophotometer at 490 nm. A test curve is established with a standard range of a combination of 1/3 of mannose, 1/3 of glucose and 1/3 of galactose, with concentrations of 25 to 100 μg / l.
Les valeurs du taux de sucre sont lues sur la courbe directement et dans le cas du principe actif selon la présente invention, on obtient des valeurs de sucres totaux comprises entre 1,5 et 70 g/1, plus particulièrement 15 et 30 g/1.The values of the sugar level are read directly from the curve and in the case of the active principle according to the present invention, values of total sugars are obtained between 1.5 and 70 g / l, more particularly 15 and 30 g / l .
2/ EVALUATION IN VITRO DE L' ACTIVITÉ PIGMENTANTE2 / IN VITRO EVALUATION OF THE PIGMENTING ACTIVITY
Le principe consiste à étudier l'activité pigmentante du principe actif selon la présente invention sur des cultures de mélanocytes par mesure de l'activité tyrosinase et du taux de mélanine synthétisée.The principle consists in studying the pigmenting activity of the active principle according to the present invention on melanocyte cultures by measuring the tyrosinase activity and the level of synthesized melanin.
Le protocole opératoire consiste à ensemencer de mélanocytes B16F1 dans un milieu complet en présence de 0,5 %, 1% et 2 % (volume /volume) du principe actif et on laisse incuber dans des conditions adaptées. On réalise parallèlement un témoin positif en présence de -MSH (Melanocyte Stimuling Hormone), hormone de stimulation de la mélanogenèse.The operating protocol consists in inoculating B16F1 melanocytes in a complete medium in the presence of 0.5%, 1% and 2% (volume / volume) of the active principle and the mixture is left to incubate under suitable conditions. A positive control is carried out in parallel in the presence of -MSH (Melanocyte Stimuling Hormone), a hormone which stimulates melanogenesis.
Les cellules sont trypsinées, comptées et lysées.The cells are trypsinized, counted and lysed.
Après centrifugation, on dose la tyrosinase à partir du surnageant et le taux de mélanine à partir du culot. 2-1 Dosage de l'activité tyrosinaseAfter centrifugation, the tyrosinase is measured from the supernatant and the melanin level from the pellet. 2-1 Determination of tyrosinase activity
On ajoute à ce surnageant de la L-DOPA. Après incubation, la densité optique DO mesurée à 490 nm permet de déterminer l'activité de la tyrosinase.L-DOPA is added to this supernatant. After incubation, the OD optical density measured at 490 nm makes it possible to determine the activity of tyrosinase.
Les résultats sont les suivants : The results are as follows:
Figure imgf000008_0001
Figure imgf000008_0001
On constate à travers les résultats une forte activité tyrosinase ayant des valeurs tout à fait comparables avec celles de l'hormone a-MSH, l'effet étant dose-dépendant.The results show a strong tyrosinase activity having values quite comparable with those of the hormone a-MSH, the effect being dose-dependent.
2-2 Dosage du taux de mélanine ;2-2 Determination of the melanin level;
Ce taux de mélanine est déterminé par rapport à une gamme étalon de mélanine synthétique allant de 0 à 500 μg/l. Les taux de mélanine synthétisée par des mélanocytes sont récapitulés dans le tableau suivant :This melanin level is determined relative to a standard range of synthetic melanin ranging from 0 to 500 μg / l. The levels of melanin synthesized by melanocytes are summarized in the following table:
Figure imgf000008_0002
Figure imgf000008_0002
On constate une très forte augmentation dose-dépendante du taux de mélanine sous l'action du principe actif.There is a very large dose-dependent increase in the level of melanin under the action of the active ingredient.
3/ EVALUATION SUR EXPLANTS DE PEAU DE L'ACTIVITÉ PIGMENTANTE On choisit des explants de peau de phototype II (phototype clair). Ces échantillons, conservés en milieu adapté, sont soumis à des irradiations d'UVB à 0,05 J/cm2 , c'est-à-dire 1 à 2 fois la dose minimale pour provoquer un érythème ce phototype clair.3 / EVALUATION ON SKIN EXPLANTS OF THE PIGMENTING ACTIVITY Skin explants of phototype II (clear phototype) are chosen. These samples, kept in a suitable medium, are subjected to UVB irradiation at 0.05 J / cm 2 , that is to say 1 to 2 times the minimum dose to cause erythema, this clear phototype.
Certains des explants sont traités en topique avec 2 mg/cm2 de principe actif selon l' invention dosé à 5% pour certains, d'autres sont traités par un milieu placebo et d'autres encore dits témoins restent uniquement dans le milieu de conservationSome of the explants are treated topically with 2 mg / cm 2 of active principle according to the invention dosed at 5% for some, others are treated with a placebo medium and others, also called controls, remain only in the conservation medium.
Les explants sont irradiés tous les jours.The explants are irradiated every day.
Les résultats sont déduits à partir des observations des coupes histologiques traitées à l'argent par la technique dite de Fontana-Masson.The results are deduced from the observations of the histological sections treated with silver by the so-called Fontana-Masson technique.
On constate sur les différentes figures que les explants des témoins traités avec le placebo ont sensiblement la même pigmentation que les explants témoins non irradiés.It can be seen from the various figures that the explants of the controls treated with the placebo have substantially the same pigmentation as the non-irradiated control explants.
Par contre, la pigmentation des explants traités avec le principe actif selon l'invention, à 5%, est importante. Cette pigmentation est d'autant plus visible que les explants sont soumis aux UVB.On the other hand, the pigmentation of the explants treated with the active principle according to the invention, at 5%, is important. This pigmentation is all the more visible as the explants are subjected to UVB.
4/ EVALUATION DE L' EFFET ACCÉLÉRATEUR DE BRONZAGE4 / EVALUATION OF THE ACCELERATING TANNING EFFECT
L'étude porte sur des volontaires humains, le but étant de quantifier l'effet accélérateur de bronzage d'une émulsion contenant 5% de principe actif selon la présente invention, pendant et après l'exposition aux UV. A cet effet, les tests sont réalisés contre placebo sur deux zones des avant- bras dont on mesure la couleur avec un Chromamètre, appareil du commerce de la marque Minolta. L' émulsion contenant le principe actif et l' émulsion placebo sont appliquées deux fois par jour pendant 15 jours puis ces zones sont irradiées deux fois à deux jours d' intervalle puis 2 jours après chaque irradiation, on mesure de nouveau la couleur des zones retenues et traitées. Les paramètres pouvant être mesurés :The study relates to human volunteers, the aim being to quantify the accelerating effect of tanning of an emulsion containing 5% of active principle according to the present invention, during and after the exposure to UV. To this end, the tests are carried out against placebo on two areas of the forearms, the color of which is measured with a Chromameter, a device of the trade of the Minolta brand. The emulsion containing the active principle and the placebo emulsion are applied twice a day for 15 days then these areas are irradiated twice at two days apart then 2 days after each irradiation, the color of the areas retained is again measured. and processed. The parameters that can be measured:
- L • la clarté (du sombre au pâle)- L • clarity (from dark to pale)
- a '• la zone de couleur des verts aux rouges.- a '• the color zone from green to red.
- b : la zone des bleus aux jaunes.- b: the area from blue to yellow.
b est le paramètre étudié car il représente la pigmentation jaune mélanique cutanée, caractéristique du bronzage.b is the parameter studied because it represents the yellow melanin skin pigmentation, characteristic of tanning.
Les résultats obtenus sont récapitulés dans le tableau suivant :The results obtained are summarized in the following table:
Figure imgf000010_0001
Figure imgf000010_0001
Après les irradiations, on a mis en évidence une augmentation importante de la pigmentation jaune cutanée de la peau qui se traduit par un bronzage plus intense.After the irradiations, a significant increase in the yellow skin pigmentation of the skin was demonstrated, which results in a more intense tan.
Une des formules cosmétiques utilisée et donc susceptible d'être réalisée industriellement comprend :One of the cosmetic formulas used and therefore capable of being produced industrially comprises:
- Alcool d'arachidyle / Alcool de béhényle / Glucoside d'arachidyl (Montanov 2002) : 3%- Arachidyl alcohol / Behenyl alcohol / Arachidyl glucoside (Montanov 2002): 3%
- Isononanoate d'isononyle (Lanol 99) : 2%- Isononyl isononanoate (Lanol 99): 2%
- Octanoate de cétéaryle (Lanol 1688) : 10% - Polyacrylamide / Isoparaffine C13-14 / Laureth-7 (Sepigel 305) : 2%- Cetaryl octanoate (Lanol 1688): 10% - Polyacrylamide / Isoparaffin C13-14 / Laureth-7 (Sepigel 305): 2%
- Principe actif- 5%- Active ingredient - 5%
- Eau : 77,5%- Water: 77.5%
- Conservateur : 0,5%. Le principe actif peut être introduit dans tout support cosmétique adapté tel qu'une émulsion, une crème, une lotion, un onguent ou une dispersion.- Preservative: 0.5%. The active principle can be introduced into any suitable cosmetic support such as an emulsion, a cream, a lotion, an ointment or a dispersion.
Ainsi, un procédé de bronzage de la peau consiste à appliquer une composition contenant de 0,1 % et 10,0 % de principe actif pour provoquer une forte augmentation de la mélanine. Thus, a method of tanning the skin consists in applying a composition containing 0.1% and 10.0% of active principle to cause a large increase in melanin.

Claims

REVENDICATIONS
1. Procédé d'obtention d'un principe actif pour la stimulation de l'activité de la tyrosinase en sorte d'augmenter la synthèse de la mélanine, caractérisé en ce qu'il consiste à réaliser successivement les étapes suivantes :1. Method for obtaining an active principle for stimulating the activity of tyrosinase so as to increase the synthesis of melanin, characterized in that it consists in successively carrying out the following steps:
- solubilisation de poudre micronisée de Citrus Aurantium Dulcis dans une solution aqueuse à raison d'au moins 50 g/1,- solubilization of micronized powder of Citrus Aurantium Dulcis in an aqueous solution at a rate of at least 50 g / 1,
- hydrolyses enzymatiques simultanées ou successives avec au moins deux enzymes choisies parmi les familles carbohydrases et protéases,- simultaneous or successive enzymatic hydrolysis with at least two enzymes chosen from the carbohydrase and protease families,
- séparation des phases soluble et insoluble par filtration, centrifugation ou décantation, et - sélection par filtration des polyphénols de type flavonones.- separation of the soluble and insoluble phases by filtration, centrifugation or decantation, and - selection by filtration of flavonone type polyphenols.
2. Principe actif obtenu par la mise en oeuvre du procédé selon la revendication 1, caractérisé en ce qu'il présente :2. Active principle obtained by implementing the method according to claim 1, characterized in that it has:
- un taux de matière sèche compris entre 5 et 200 g/1- a dry matter content of between 5 and 200 g / 1
- un pH compris entre 3,0 et 7,0 - un taux de composés phénoliques compris entre 1,5 et 70 g/1- a pH between 3.0 and 7.0 - a level of phenolic compounds between 1.5 and 70 g / 1
- un taux d'au moins 35 % en flavonones des polyphénols, et- a level of at least 35% in flavonones of the polyphenols, and
- une teneur en sucres totaux comprise entre 1,5 et 70 g/1.- a total sugar content between 1.5 and 70 g / 1.
3. Principe actif selon la revendication 2, caractérisé en ce qu'il présente •3. Active ingredient according to claim 2, characterized in that it has •
- un taux de matière sèche compris entre 50 et 85 g/1 - un pH compris entre 4,5 et 5,5- a dry matter content between 50 and 85 g / 1 - a pH between 4.5 and 5.5
- un taux de composés phénoliques compris entre 15 et 30 g/1- a level of phenolic compounds between 15 and 30 g / 1
- un taux d'au moins 50 % en flavonones des polyphénols, et- a level of at least 50% in flavonones of the polyphenols, and
- une teneur en sucres totaux comprise entre 15 et 30 g/1. - a total sugar content between 15 and 30 g / 1.
4. Procédé de bronzage de la peau par application du principe actif selon la revendication 2 ou 3, caractérisé en ce qu'il provoque une forte augmentation de la mélanine lorsque ledit principe actif est dosé entre 0,1% et 10,0 %.4. A method of tanning the skin by applying the active ingredient according to claim 2 or 3, characterized in that it causes a large increase in melanin when said active ingredient is dosed between 0.1% and 10.0%.
5. Composition cosmétique destinée à favoriser le bronzage de la peau, caractérisée en ce qu'elle comprend entre 0,1% et 10,0 % de principe actif selon la revendication 2 ou 3 sous une forme galénique telle qu'une crème, un onguent, une émulsion ou encore une dispersion. 5. Cosmetic composition intended to promote the tanning of the skin, characterized in that it comprises between 0.1% and 10.0% of active principle according to claim 2 or 3 in a galenical form such as a cream, a ointment, an emulsion or a dispersion.
PCT/FR2003/002942 2002-10-07 2003-10-07 Method for obtaining an active principle stimulating suntan and resulting active principle WO2004032890A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003299762A AU2003299762A1 (en) 2002-10-07 2003-10-07 Method for obtaining an active principle stimulating suntan and resulting active principle

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR02/12421 2002-10-07
FR0212421A FR2845285B1 (en) 2002-10-07 2002-10-07 METHOD FOR OBTAINING AN ACTIVE TANNING STIMULATION PRINCIPLE AND ACTIVE INGREDIENT

Publications (2)

Publication Number Publication Date
WO2004032890A2 true WO2004032890A2 (en) 2004-04-22
WO2004032890A3 WO2004032890A3 (en) 2004-06-03

Family

ID=32011462

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/002942 WO2004032890A2 (en) 2002-10-07 2003-10-07 Method for obtaining an active principle stimulating suntan and resulting active principle

Country Status (3)

Country Link
AU (1) AU2003299762A1 (en)
FR (1) FR2845285B1 (en)
WO (1) WO2004032890A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881953A1 (en) * 2005-02-11 2006-08-18 Greenpharma Sa Sa USE OF TAXIFOLINE DERIVATIVES AS PIGMENTANTS AND PROTECTIVE AGENTS FOR SKIN OR HAIR

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2014276A1 (en) * 2007-06-20 2009-01-14 Cognis IP Management GmbH Cosmetic compositions comprising sclareolide and hesperidin methyl chalcone
EP2505185B1 (en) * 2011-03-31 2015-03-25 Coty Germany Gmbh Composition with improved tanning effect

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660818A (en) * 1994-05-05 1997-08-26 L'oreal Bioflavonoids as agents for protecting the physical and/or cosmetic properties of keratinous superficial body growths
DE19830004A1 (en) * 1998-06-24 1999-12-30 Coty Bv Cosmetic composition with high radical protection factor
DE19917836A1 (en) * 1999-04-20 2000-10-26 Cs Dental Gmbh Natural preservative, effective against bacteria, fungi, parasites and viruses and useful e.g. in cosmetics, foods or water treatment, comprises citrus fruit extract or diphenolbenzene complex
WO2002030371A1 (en) * 2000-10-09 2002-04-18 L"Oreal Dyeing composition promoting natural pigmentation, method for obtaining same and use for colouring the skin and/or keratinous fibres

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660818A (en) * 1994-05-05 1997-08-26 L'oreal Bioflavonoids as agents for protecting the physical and/or cosmetic properties of keratinous superficial body growths
DE19830004A1 (en) * 1998-06-24 1999-12-30 Coty Bv Cosmetic composition with high radical protection factor
DE19917836A1 (en) * 1999-04-20 2000-10-26 Cs Dental Gmbh Natural preservative, effective against bacteria, fungi, parasites and viruses and useful e.g. in cosmetics, foods or water treatment, comprises citrus fruit extract or diphenolbenzene complex
WO2002030371A1 (en) * 2000-10-09 2002-04-18 L"Oreal Dyeing composition promoting natural pigmentation, method for obtaining same and use for colouring the skin and/or keratinous fibres

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS, [en ligne] XP002274511 Extrait de l'Internet: <URL:http://web.archive.org/web/2002082404 5153/http://www.gattefosse.com/cosmetic/ma inbib2.htm> [extrait le 2004-03-23] *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881953A1 (en) * 2005-02-11 2006-08-18 Greenpharma Sa Sa USE OF TAXIFOLINE DERIVATIVES AS PIGMENTANTS AND PROTECTIVE AGENTS FOR SKIN OR HAIR
US8569358B2 (en) 2005-02-11 2013-10-29 Greenpharma Use of silymarin and/or constituents thereof as skin or hair pigmentation promoters

Also Published As

Publication number Publication date
FR2845285B1 (en) 2005-06-24
AU2003299762A8 (en) 2004-05-04
FR2845285A1 (en) 2004-04-09
AU2003299762A1 (en) 2004-05-04
WO2004032890A3 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
CA2657703C (en) Use of a rice protein hydrolysate as pigmenting active principle
EP1776082B1 (en) Use of a cruciferous protein hydrolysate as a depigmentation agent or for a cosmetic and/or pharmaceutical composition
FR3065172A1 (en) COSMETIC PREPARATION CONTAINING WHITE TRUFFLE EXTRACT AND ASSOCIATED COSMETIC PROCESS
FR2751874A1 (en) NEW COSMETIC COMPOSITIONS TO ENHANCE AND BRIGHTEN SKIN
FR2928263A1 (en) PROCESS FOR COSMETIC TREATMENT BASED ON POLYPHENOLS OF FRUIT OR VEGETABLES
WO2021156104A1 (en) Method for obtaining an aqueous extract of lavender, compositions comprising such an extract and their cosmetic uses
EP0993826B1 (en) Use of a Sanguisorba officinalis extract to stimulate the skin- and/or the hair-pigmentation
EP0814763B1 (en) Depigmenting dermatological and/or cosmetic composition
WO2002015871A1 (en) Use of tyramine in cosmetic compositions to lighten the skin
EP3980124B1 (en) Extract of moringa peregrina seed cake, method for obtaining same and use thereof in cosmetic or nutricosmetic compositions
FR2698785A1 (en) Compsn. to stimulate melanogenesis contg. arachidonic acid or a deriv. - and a non-saponifiable vegetable fraction as a potentiator, for treating vitiligo and to tan skin and treat grey hair.
FR2803200A1 (en) Topical cosmetic composition, useful for protecting skin and hair against sunlight, contains an extract from the red alga Polysiphonia lanosa
KR100905388B1 (en) Leaf extract of fragaria ananassa duchesne complex having skin whitening activity containing ellagic acid
WO2004032890A2 (en) Method for obtaining an active principle stimulating suntan and resulting active principle
JP2005514436A (en) Whitening composition
FR3100129A1 (en) New anti-hyperpigmentation spot composition
EP3288575B1 (en) Bioassimilable protein-melanin complex, preparation and uses
WO2010100341A1 (en) Cosmetic treatment method using polyphenols and fruit acids from fruits or vegetables
US6551581B1 (en) Methods for improving the aesthetic appearance of skin and hair
US5266307A (en) Retinoic acid as a skin tanning agent in persons of light skin color
EP2198847A2 (en) Compositions comprising self-tanning agents and plant extracts
WO2004032892A1 (en) Method for obtaining an active principle having a skin pigmenting activity, resulting active principle and cosmetic composition comprising same
FR3097767A1 (en) Active ingredient obtained from flowers of Nymphaea alba
FR3089974A1 (en) New depigmenting compounds extracted from Eryngium maritimum
EP2198848A2 (en) Compositions comprising self-tanning agents and sugar amines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP